Site Location: Home > Client Services > Planning Services > Life Sciences
Strategic Portfolio Review services
Pharmaceutical companies consider Strategic Portfolio Management a key driver of shareholder value. Strategic portfolio decisions are crucial to the viability and success of the company, and management has to decide which projects should be funded in order to create the most value for the firm. It is one of the most difficult questions that companies face: what allocation of resources to business units, product lines, R&D projects, or other business initiatives will best balance risk diversification, short-term earnings, and long-term shareholder value?
Portfolio Strategy
With an effective portfolio management process, strategic objectives are set with respect to investors, customers and competitors. Internal resources are allocated with respect to strategic requirements and likely returns on investment. Portfolio management tools and Applied Decision Analysis provide a central hub connecting the key decision-making elements in the portfolio management process.
How Expantium can help
Expantium’s Strategic Portfolio Review services helps corporations develop strategies, allocate resources and manage their portfolios of businesses for maximum shareholder value. Expantium helps to find the right strategies for individual R&D or technology investments and determine the optimal allocation of resources across the portfolio to increase its value and return. We provide unique methodologies and risk assessment tools that enable decision-makers to identify creative options, reprioritize resource allocations and expand your position in target markets. We detail the value of discoveries in clinical phases, candidates in the pipeline and products on the market, enabling executives to make strategic investment, licensing and prioritization decisions to realise their company’s full potential.
Key portfolio management issues that we address:
| |
Which technologies and product candidates have the greatest potential commercial value? |
| |
We need to improve our Cash Flow; in which areas could we save considering the strategic outlook? |
| |
What actions can we take to accellerate or maximize return on investment for individual discoveries? |
| |
How can we maximize return on investment for the company as a whole? |
| |
Which proprietary rights should we buy, co-market, license, or sell? |
<< Back to the Overview
To find out more about Expantium's work in this solution area or how we can support the growth objective of your organisation, please contact lifesciences@expantium.com, call us or complete the contact form.
